Fundraising FoxFibrocor
1 known investors
Find your way into Fibrocor
Sign up to see every warm intro you have to Fibrocor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fibrocor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fibrocor Therapeutics is a drug developer building a pipeline of first-in-class therapeutics that target fibroblast activation to treat fibrotic diseases, with an initial focus on the genetic kidney diseases Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease (ADPKD). It uses human biopsy transcriptomic analysis and access to a fibrosis tissue biobank of kidney, liver, and lung samples to identify disease-relevant, druggable targets.
Investors · 1
Frequently asked questions
- What does Fibrocor do?
- Fibrocor Therapeutics is a drug developer building a pipeline of first-in-class therapeutics that target fibroblast activation to treat fibrotic diseases, with an initial focus on the genetic kidney diseases Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease (ADPKD). It uses human biopsy transcriptomic analysis and access to a fibrosis tissue biobank of kidney, liver, and lung samples to identify disease-relevant, druggable targets.
- Who are Fibrocor's investors?
- Fibrocor's investors include BioGeneration Ventures.